These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 2659004)
1. [Development of human monoclonal antibodies. Current status and future development]. Gebauer W; Lindl T Arzneimittelforschung; 1989 Feb; 39(2):287-91. PubMed ID: 2659004 [TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. Development of the human monoclonal antibodies. Lindl T ALTEX; 1995; 12(1):13-23. PubMed ID: 11178412 [TBL] [Abstract][Full Text] [Related]
4. The use of Epstein-Barr virus transformation for the production of human monoclonal antibodies. Roome AJ; Reading CL Exp Biol; 1984; 43(1):35-55. PubMed ID: 6099808 [TBL] [Abstract][Full Text] [Related]
5. [Monoclonal antibodies and therapeutics]. Desgranges C Pathol Biol (Paris); 2004 Jul; 52(6):351-64. PubMed ID: 15261379 [TBL] [Abstract][Full Text] [Related]
6. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
7. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
8. Immunology: current and future technology assessment. Maggio ET; Nakamura RM Clin Lab Med; 1981 Mar; 1(1):77-109. PubMed ID: 7049515 [No Abstract] [Full Text] [Related]
9. Beware the Medical-Industrial Complex. Stevens CW; Glatstein E Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005 [TBL] [Abstract][Full Text] [Related]
10. Engineered antibodies take center stage. Huston JS; George AJ Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424 [TBL] [Abstract][Full Text] [Related]
11. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells. Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436 [TBL] [Abstract][Full Text] [Related]
12. In vitro generated human monoclonal trinitrophenyl-specific B cell lines. Evidence that human and murine anti-trinitrophenyl monoclonal antibodies cross-react with Escherichia coli beta-galactosidase. Golding B; Inghirami G; Peters E; Hoffman T; Balow JE; Tsokos GC J Immunol; 1987 Dec; 139(12):4061-6. PubMed ID: 2826579 [TBL] [Abstract][Full Text] [Related]
13. Human monoclonal antibodies isolated from spontaneous Epstein-Barr virus-transformed tumors of Hu-SPL-SCID mice and specific for fusion protein display broad neutralizing activity toward respiratory syncytial virus. Chamat S; Walsh EE; Anderson D; Osta M; Awaraji C; Pan LZ; Ochi J; Shuey S; Brams P J Infect Dis; 1999 Aug; 180(2):268-77. PubMed ID: 10395839 [TBL] [Abstract][Full Text] [Related]
17. Human monoclonal antibodies to viral peptides. Sidorova E; Borisova T; Lyakisheva L; Rosen A Hum Antibodies; 1997; 8(2):65-9. PubMed ID: 9289390 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies, antigens and molecular diagnostics: a practical overview. Laurino JP; Shi Q; Ge J Ann Clin Lab Sci; 1999; 29(3):158-66. PubMed ID: 10440578 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes]. Siberil S; Dutertre CA; Boix C; Teillaud JL Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389 [TBL] [Abstract][Full Text] [Related]
20. [Allergology in the year 2000]. Blaser K; Simon HU Ther Umsch; 1994 Jan; 51(1):19-23. PubMed ID: 8146809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]